Skip to main content
logo
Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
9.34
+0.19 (2.08%)
May 29, 2026, 12:56 PM EDT - Market open

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Laboratory Solutions Revenue
-4.40B4.61B
Laboratory Solutions Revenue Growth
--4.56%-2.71%
Bioscience Production Revenue
-2.15B2.17B
Bioscience Production Revenue Growth
--0.97%-2.49%
Revenue (Total)
6.55B6.55B6.78B
Revenue (Total) Growth
--3.41%-2.63%

Adjusted EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Corporate Adjusted Operating Income
-68.30M-70.40M-66.40M
Operating Income (Other)
-225.80M-175.80M1.15B
Operating Income (Total)
-294.10M-246.20M1.08B
Operating Income (Total) Growth
--55.77%

Adjusted EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Corporate Adjusted Operating Income
-68.30M-70.40M-66.40M
Laboratory Solutions Adjusted Operating Income
-510.40M598.00M
Laboratory Solutions Adjusted Operating Income Growth
--14.65%-10.52%
Bioscience Production Adjusted Operating Income
-517.80M558.20M
Bioscience Production Adjusted Operating Income Growth
--7.24%-7.26%
Operating Income (Total)
-294.10M-246.20M1.08B
Operating Income (Total) Growth
--55.77%
Updated Apr 29, 2026. Data Source: Fiscal.ai.